A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director, Digital HR Platforms

Enterprise ApplicationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$205.7k - $278.3k

About the Job

Requirements

  • A bachelor's degree in Human Resources, Information Systems, Business, or a related field, or equivalent experience.
  • At least 10 years of progressive experience in HR technology, digital platforms, or enterprise systems leadership.
  • Experience managing SuccessFactors as an enterprise Human Capital Management solution.
  • Demonstrated success leading integrations, data governance initiatives, and large-scale platform optimization.
  • Experience with AI, automation, or digital enablement.

Responsibilities

  • Develop and execute a multi-year digital HR platform strategy aligned to HR, business, and enterprise technology priorities.
  • Serve as the platform owner for SuccessFactors, including Core HR, Compensation, Benefits, Talent Management, Time Tracking, and Learning, ensuring cohesive architecture and user experience.
  • Drive platform design decisions that balance standardization, scalability, and business evolution.
  • Ensure platform stability, data integrity, role-based security, and compliance with regulatory requirements.
  • Oversee the product roadmap across all SuccessFactors modules, ensuring alignment with business needs and enterprise architecture.
  • Lead the development of HR data foundations, including data models, data flows, and data quality frameworks.
  • Establish and maintain HR data governance standards in partnership with HR, IT, and enterprise data teams.
  • Ensure HR data is accurate, accessible, and structured to support analytics, reporting, and AI-driven insights.
  • Partner with the Insights & Innovation team to enable advanced analytics and workforce planning capabilities.
  • Oversee the design, development, and maintenance of integrations across HR, IT, Finance, and enterprise systems.
  • Lead release management processes, including regression testing, change control, and communication.
  • Ensure seamless coordination with IT on architecture, middleware, and integration standards.
  • Maintain documentation, audit readiness, and operational support processes.
  • Identify opportunities to apply AI, automation, and workflow orchestration across HR platforms.
  • Partner with HR Innovation, Analytics, and IT to scale digital solutions such as generative AI, intelligent case management, and automated workflows.
  • Promote digital-first, self-service, and automation-oriented approaches across HR operations.
  • Stay current with emerging HR technologies and evaluate tools that enhance scalability and innovation.
  • Act as the strategic partner to HR centers of excellence, HR business partners, People Operations, IT, Finance, Legal, and other stakeholders.
  • Translate business requirements into scalable platform and data solutions.
  • Lead HR technology governance forums to prioritize demand, manage enhancements, and align stakeholders on roadmap decisions.
  • Support change management, communication, and adoption efforts to maximize value from HR platforms.
  • Build and lead a high-performing team across platform management, data governance, integrations, and release management.
  • Foster a culture of accountability, continuous improvement, and innovation.
  • Serve as a visible leader and subject matter expert across HR and the enterprise.

Desired Qualifications

  • Experience in global and/or regulated environments.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs